A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
Clinical trial NCT02364947 · COMPLETED
Trial details
- NCT number
- NCT02364947
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-09
- Primary completion
- 2016-07-30
- Enrollment
- 678
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.